| ID | Title | Body | Facebook Description | Facebook image | Facebook Title | Facebook Video | Twitter Description | Twitter Image | Twitter Title | Meta tags |
|---|---|---|---|---|---|---|---|---|---|---|
| 8335 | Extracellular RNA Communication (ExRNA) | ExRNA communication is a recently discovered cell-to-cell signaling process that holds enormous promise for improving our understanding of a wide variety of diseases. NCATS participates in the NIH Common Fund's program to investigate this new scientific field. | ||||||||
| 8268 | Assay Development and Screening Technology (ADST) | Advancing therapeutic development through research and development of innovative assay (test) designs and chemical library screening methods. Learn more. | Advancing therapeutic development through research and development of innovative assay (test) designs and chemical library screening methods | /sites/default/files/ipglycermide-900.jpg | Assay Development and Screening Technology (ADST) | Advancing therapeutic development through research and development of innovative assay (test) designs and chemical library screening methods | /sites/default/files/ipglycermide-900.jpg | Assay Development and Screening Technology (ADST) | ||
| 8267 | Rare Diseases Clinical Research Network (RDCRN) | The RDCRN program is designed to advance medical research on rare diseases by providing support for clinical studies and facilitating collaboration, study enrollment and data sharing. Through the RDCRN consortia, physician scientists and their multidisciplinary teams work together with patient advocacy groups to study more than 200 rare diseases at sites across the nation. | The RDCRN program is designed to advance medical research on rare diseases by providing support for clinical studies and facilitating collaboration, study enrollment and data sharing. | Rare Diseases Clinical Research Network (RDCRN) | The RDCRN program is designed to advance medical research on rare diseases by providing support for clinical studies and facilitating collaboration, study enrollment and data sharing. | Rare Diseases Clinical Research Network (RDCRN) | ||||
| 8266 | Strategic Alliances | The Strategic Alliances team at NCATS helps industry and academia interact and partner with NCATS laboratories and scientists. Learn more. | NCATS' Strategic Alliances team helps industry and academia interact and partner with NCATS laboratories and scientists. | Strategic Alliances at NCATS | NCATS' Strategic Alliances team helps industry and academia interact and partner with NCATS laboratories and scientists. | Strategic Alliances at NCATS | ||||
| 8265 | Core Technologies | Using state-of-the-art resources to enable the ongoing operation of all NCATS translational research activities. | ||||||||
| 8264 | Testing & Predictive Models | Developing better model systems for drug and toxicity testing. Learn more. | ||||||||
| 8263 | Preclinical Innovation | NCATS develops novel approaches to improve the process of joining basic science discoveries with initial testing of therapies in humans. | NCATS develops novel approaches to improve the process of joining basic science discoveries with initial testing of therapies in humans. | /sites/default/files/stemcell-video-900x600.jpg | Preclinical Innovation | NCATS develops novel approaches to improve the process of joining basic science discoveries with initial testing of therapies in humans. | /sites/default/files/stemcell-video-900x600.jpg | Preclinical Innovation | ||
| 8262 | Repurposing Drugs | Discovering new uses for approved drugs to provide the quickest possible transition from bench to bedside. | ||||||||
| 8261 | Clinical Innovation | NCATS supports innovation in new technologies and other clinical and translational approaches that may greatly accelerate the process of transforming laboratory discoveries into new treatments for patient. | NCATS supports innovation in new technologies and other clinical and translational approaches that may greatly accelerate the process of transforming laboratory discoveries into new treatments | /sites/default/files/ctsa-goal1.jpg | Clinical Innovation | NCATS supports innovation in new technologies and other clinical and translational approaches that may greatly accelerate the process of transforming laboratory discoveries into new treatments | /sites/default/files/ctsa-goal1.jpg | Clinical Innovation | ||
| 8260 | Improving the Drug Development Process | Creating and testing innovative methods to improve and accelerate the drug development process and find new treatments for patients faster. Learn more. |
Last updated on